News you can use: health & drug safety updates

2007

  • August 15, 2007
    The FDA announced that, in October, the Nonprescription Drugs Advisory Committee will discuss the safety and effectiveness of cough and cold drug product use in children. Questions have been raised about the safety of these products and whether the benefits justify any potential risks from the use of these products in children, especially in children under 2 years of age. Reports of serious adverse events associated with the use of these products appear to be the result of giving too much of these medicines to children. An over-the-counter (OTC)
  • August 15, 2007
    A number of national pharmacy organizations, emergency preparedness groups and a pharmaceutical trade association announced creation of Rx Response a program designed to help support the continued delivery of medicines during a severe public health emergency. The partnership includes the American Hospital Association, American Red Cross, Biotechnology Industry Organization, Healthcare Distribution Management Association, National Association of Chain Drug Stores, and the National Community Pharmacists Association.. Additionally, the partnership
  • August 3, 2007
    The National Council on Patient Information and Education (NCPIE) today released, “Enhancing Prescription Medicine Adherence: A National Action Plan.” The report offers a comprehensive review of the extent and nature of poor medicine adherence, its health and economic costs, and its underlying factors. Included are 10 action steps / recommendations that can significantly impact medication adherence and can be readily implemented.
  • August 3, 2007
    The National Academies
  • August 1, 2007
    Economic Consequences
  • July 30, 2007
    AP News
  • June 15, 2007
    U.S. Senator Joseph R. Biden, Jr., (D-Del.) introduced a Senate resolution designating August 2007 as “National Medicine Abuse Awareness Month.” The initiative highlights the month of August—when students nationwide will be preparing for the upcoming school year - as an opportunity for parents to educate themselves and to talk to their teens about the dangers associated with medicine abuse. For more, see: www.stopmedicineabuse.org/
  • June 14, 2007
    AHRQ’s latest Healthcare 411 audio podcast (Reference: “Lab Tests,” June 6, 2007) features AHRQ Director Carolyn Clancy, M.D. discussing the importance of common blood tests and other screening tests. Lab tests can help monitor the effectiveness or possible adverse effects of some medicines. You can listen to the audio program directly through your computer if it has a sound card and speakers and can play MP3 audio files, or you can download it to a portable audio device. In any case, you will be able to listen at your convenience.
  • May 21, 2007
    The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia. However, other published and unpublished data from long-term clinical trials of Avandia, including an interim analysis of data from the RECORD trial (a large, ongoing, randomized open label trial) and unpublished reanalyses of data
  • April 13, 2007
    In 2004, 1.2 million hospitalized patients experienced an adverse drug event, 90 percent of which were due to a side effect from a medication that was properly administered. Average total hospital costs for patients who experienced drug side effects or other adverse drug events were $10,100, compared with an average cost of $7,600 for patients who didn't experience adverse drug events.

Pages